Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2989-2992

  Ardavanis, A ^a,b   Kountourakis, P ^a   Maliou, S ^a   Vassilakopoulou, M ^a   Basioukas, S ^a   Kyriakou, F ^a   Koumna, S ^a   Rigatos, G ^a  

^a Anticancer Hospital Agios Sabas   (Greece)

^b Department of Hematology Saint Savvas   (Greece)

Author keywords

Breast cancer; Gemcitabine; Oral vinorelbine; Salvage treatment

Indexed keywords

ANTHRACYCLINE; GEMCITABINE; NAVELBINE; TAXANE DERIVATIVE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; LEUKOPENIA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PHLEBITIS; PRIORITY JOURNAL; SALVAGE THERAPY; SENSORY DYSFUNCTION; THROMBOCYTOPENIA; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; MIDDLE AGED; SALVAGE THERAPY; TAXOIDS; VINBLASTINE;

EID: 34547818235     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics 2000. CA Cancer J Clin 50(1): 7-33, 2000.
2. Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC and Grindley GB: Evaluation of the antitumor activity of gemcitabine. Cancer Res 50: 4417-4422, 1990.
3. Budman DR: Vinorelbine (Navelbine). A third generation vinca alkaloid. Cancer Invest 15: 475-490, 1997.
4. Herbst R, Lynch C, Vasconcelles M, Teicher B, Strauss G, Elias A, Anderson I, Zacarola P, Dang H, Leonq T, Salgia R and Skavin AT: Gemcitabine and vinorelbine in patients with lung cancer: preclinical studies and report of phase I trial.Cancer Chemother Pharmacol 45(2): 151-159, 2001.
5. Martoni AA, Di Fabio F, Melotti B, Giaquinta S and Guaraldi M: Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer. Anticancer Res 26(2B): 1501-1508, 2006.
6. Harris J, Morrow M and Norton L: Malignant tumors of the breast: management of metastatic disease. In: DeVita VT, Hellman S and Rosenburg SA (eds.). Cancer Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven Publishers, pp. 1602-1616, 1997.
7. Herbst R, Dang N and Lynch C: A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane. Clin Breast Cancer 6(1): 55-56, 2005.
8. Weber BL, Vogel C, Jones S, Harvey H, Hutchins L, Bigley J and Hohneker J: Intravenous vinorelbine as first line and second line therapy in advanced breast cancer. J Clin Oncol 13: 2722-2730, 1995.
9. Fumoleau P, Delgado FM, Delozier T, Monnier A, Gil Delgado MA, Kerbrat P, Garcia-Giralt E, Keiling R, Namer M and Closon MT: Phase II trial of weekly intravenous vinorelbine as first line advanced breast cancer chemotherapy. J Clin Oncol 11: 1245-1252, 1993.
10. Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis A, Horner D and Demaille A: Vinorelbine (Navelbine) as salvage treatment for advanced breast cancer. Ann Oncol 5: 423-426, 1994.
11. Livingston RB, Ellis GK, Gralow JR, Williams MA, White R, McGuirt C, Adamkiewicz BB and Long CA: Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 15: 1395-1400, 1997.
12. Nicolaides C, Dimopoulos MA, Samantas E, Bafaloukos D, Kalofonos C, Fountzilas G, Razi E, Kosmidis P and Pavlidis N: Gemcitabine and vinorelbine as second line treatment in patients with metastatic breast cancer progressing after first line taxane-based chemotherapy:A phase II study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 11: 873-875, 2000.
13. Mariani G, Tagliabue P, Zucchinelli P, Brambilla C, Demicheli R, Villa E, Marchiano A, Valaqussa P, Bonadonna G and Gianni L: Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer. Breast Cancer Res Treat 70: 163-169, 2001.
14. Stathopoulos GP, Rigatos S, Pergantas N, Tsavdarides D, Athanassiadis I, Malamos NA and Stathopoulos JG: Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer. J Clin Oncol 20(1): 37-41, 2002.
15. Morabito A, Filippelli G, Palmeri S, Cascinu S, Ferrau F, Zagonel V, Gattuso D, Catalano V, Capaccetti B, Franciosi V, Accurso V, Scinto F and Gasparini G: The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study. Breast Cancer Res Treat 78(1): 29-36, 2003.
16. Donadio M, Ardine M, Berruti A, Ritorto G, Fea F, Mistrangelo M, Coccorullo Z, Bergnolo P, Comandone A and Bertetto O: Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. Cancer Chemother Pharmacol 52(2): 147-152, 2003.
17. Dinota A, Bilancia D, Romano R and Manzione L: Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer. Breast Cancer Res Treat 89(1): 1-3, 2005.
18. Gennatas C, Michalaki V, Mouratidou D, Tsavaris N, Andreadis C, Psychogios J and Poulakaki N: Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer Anticancer Res 26(1B): 549-552, 2006.
19. Marty M, Fumoleau P, Adenis A, Rousseau Y, Merrouche Y, Robinet G, Senac I and Puozzo C: Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors. Ann Oncol 12(11): 1643-1649, 2001.
20. Cebbia V and Puozzo C: Oral versus intravenous vinorelbine: clinical safety profile.Expert Opin Drug Saf 4(5): 915-928, 2005.
21. Lorusso V, Carpagnano F, Frasci G, Panza N, Di Rienzo G, Cisternino ML, Napoli G, Orlando S, Cinieri S, Brunetti C, Palazzo S and De Lena M: Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol 18(2): 405-411, 2000.
22. Frasci G, Lorusso V, Panza N, Cornelia P, Nicolella G, Bianco A, De Cataldis G, Ianelli A, Billancia D, Belli M, Massidda B, Piantedosi F, Comella G and De Lena M: Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non small-cell lung cancer. J Clin Oncol 18(13): 2529-2536, 2000.